A first-of-its-kind facility in the region to manufacture life-saving drugs; Mubadala has invested in several equity rounds of Resilience
G42 Healthcare
Mubadala Health and G42 Healthcare merger promises future-ready healthcare in the UAE
The new, yet-unnamed, company will bring together Mubadala’s world-class patient care and G42’s artificial intelligence and data-driven technologies
ZHO conducts third stage of Emirati Genome Programme for people of determination
The genome programme initiative, launched in collaboration with G42 Health Care, is aimed at improving the general wellness and curbing the occurrence of disability
Abu Dhabi’s G42, Amazon Web Services partner to launch genome sequencing service
The deal allows G42 Healthcare to offer its sequencing, proteomics, and data analytics capabilities “to governments, population genome programs, and life science initiatives across the world”
G42 Healthcare, KSM enter first UAE-Israel genetic research collaboration
Researchers from UAE and Israel will try to accurately characterise the phenomenon of vitamin D deficiency, which is particularly prevalent in the Middle East, and is associated with chronic diseases.
UAE approves new Sinopharm CNBG vaccine for emergency use
Hayat Biotech, a joint venture between Abu Dhabi-based G42 and Chinese drug maker Sinopharm CNBG, will produce the new vaccine
Masdar City eyes key role in global green recovery from Covid crisis
The number of companies in the Masdar City free zone increased 26% in 2020